Browse > Article
http://dx.doi.org/10.3340/jkns.2015.57.6.408

Moyamoya Syndrome : A Window of Moyamoya Disease  

Phi, Ji Hoon (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine)
Wang, Kyu-Chang (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine)
Lee, Ji Yeoun (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine)
Kim, Seung-Ki (Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine)
Publication Information
Journal of Korean Neurosurgical Society / v.57, no.6, 2015 , pp. 408-414 More about this Journal
Abstract
Moyamoya-like vasculopathy develops in association with various systemic diseases and conditions, which is termed moyamoya syndrome. Relatively common diseases and conditions are related to moyamoya syndrome, including neurofibromatosis type 1, Down syndrome, thyroid disease, and cranial irradiation. Moyamoya syndrome shares phenotypical characteristics with idiopathic moyamoya disease. However, they differ in other details, including clinical presentations, natural history, and treatment considerations. The study of moyamoya syndrome can provide clinicians and researchers with valuable knowledge and insight. Although it is infrequently encountered in clinical practice, moyamoya-like vasculopathy can severely complicate outcomes for patients with various underlying diseases when the clinician fails to expect or diagnose moyamoya syndrome development. Furthermore, moyamoya syndrome could be used as a doorway to more enigmatic moyamoya disease in research. More comprehensive survey and investigation are required to uncover the secrets of all the moyamoya-like phenomena.
Keywords
Moyamoya syndrome; Neurofibromatosis; Down syndrome; Thyroid disease; Radiation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Cairns AG, North KN : Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 79 : 1165-1170, 2008   DOI
2 Seol HJ, Shin DC, Kim YS, Shim EB, Kim SK, Cho BK, et al. : Computational analysis of hemodynamics using a two-dimensional model in moyamoya disease. J Neurosurg Pediatr 5 : 297-301, 2010   DOI
3 Chiang CS, Hong JH, Stalder A, Sun JR, Withers HR, McBride WH : Delayed molecular responses to brain irradiation. Int J Radiat Biol 72 : 45-53, 1997   DOI
4 Ghosh PS, Rothner AD, Emch TM, Friedman NR, Moodley M : Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol 28 : 95-101, 2013   DOI
5 Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. : A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56 : 34-40, 2011   DOI
6 Sobata E, Ohkuma H, Suzuki S : Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis : a case report. Neurosurgery 22 : 544-549, 1988   DOI
7 Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, et al. : The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg 99 Suppl 2 : S221-S224, 1997
8 Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K : Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg 31 : 45-48, 1999   DOI
9 Bajaj A, Li QF, Zheng Q, Pumiglia K : Loss of NF1 expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis. PLoS One 7 : e49222, 2012   DOI
10 Berk AT, Saatci AO, Erçal MD, Tunç M, Ergin M : Ocular findings in 55 patients with Down's syndrome. Ophthalmic Genet 17 : 15-19, 1996   DOI
11 Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. : Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors : a report from the Childhood Cancer Survivor Study. J Clin Oncol 24 : 5277-5282, 2006   DOI
12 Czarkowski M, Hilgertner L, Powałowski T, Radomski D : The stiffness of the common carotid artery in patients with Graves' disease. Int Angiol 21 : 152-157, 2002
13 Desai SS, Paulino AC, Mai WY, Teh BS : Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 65 : 1222-1227, 2006   DOI
14 Fajardo LF : The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44 : 13-22, 2005   DOI
15 Franklyn JA, Boelaert K : Thyrotoxicosis. Lancet 379 : 1155-1166, 2012   DOI
16 Im SH, Oh CW, Kwon OK, Kim JE, Han DH : Moyamoya disease associated with Graves disease : special considerations regarding clinical significance and management. J Neurosurg 102 : 1013-1017, 2005   DOI
17 Fulcher T, Griffin M, Crowley S, Firth R, Acheson R, O'Meara N : Diabetic retinopathy in Down's syndrome. Br J Ophthalmol 82 : 407-409, 1998   DOI
18 Hasle H, Clemmensen IH, Mikkelsen M : Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355 : 165-169, 2000   DOI
19 Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T : Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64 : 533-537, 1999   DOI
20 Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M : Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15 : 179-182, 2000   DOI
21 Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA : Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7 : 353-361, 1994   DOI
22 Jea A, Smith ER, Robertson R, Scott RM : Moyamoya syndrome associated with Down syndrome : outcome after surgical revascularization. Pediatrics 116 : e694-e701, 2005   DOI
23 Jeong HC, Kim YJ, Yoon W, Joo SP, Lee SS, Park YW : Moyamoya syndrome associated with systemic lupus erythematosus. Lupus 17 : 679-682, 2008   DOI
24 Jett K, Friedman JM : Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12 : 1-11, 2010
25 Kainth DS, Chaudhry SA, Kainth HS, Suri FK, Qureshi AI : Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease. Neurosurgery 72 : 210-215; discussion 215, 2013   DOI
26 Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ : Moyamoya syndrome associated with neurofibromatosis Type 1 : perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr 11 : 417-425, 2013   DOI
27 Keene DL, Johnston DL, Grimard L, Michaud J, Vassilyadi M, Ventureyra E : Vascular complications of cranial radiation. Childs Nerv Syst 22 : 547-555, 2006   DOI
28 Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, et al. : Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease : a prospective study. Stroke 41 : 173-176, 2010   DOI
29 Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. : Pediatric moyamoya disease : an analysis of 410 consecutive cases. Ann Neurol 68 : 92-101, 2010   DOI
30 Kuroda S, Houkin K : Moyamoya disease : current concepts and future perspectives. Lancet Neurol 7 : 1056-1066, 2008   DOI
31 Lee HS, Seol HJ, Kong DS, Shin HJ : Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children. J Korean Neurosurg Soc 50 : 535-537, 2011   DOI
32 Leno C, Mateo I, Cid C, Berciano J, Sedano C : Autoimmunity in Down's syndrome : another possible mechanism of Moyamoya disease. Stroke 29 : 868-869, 1998   DOI
33 Malav IC, Kothari SS : Renal artery stenosis due to neurofibromatosis. Ann Pediatr Cardiol 2 : 167-169, 2009   DOI
34 Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. : Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70 (24 Pt 2) : 2357-2363, 2008   DOI
35 Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. : Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78 : 803-810, 2012   DOI
36 Panegyres PK, Morris JG, O'Neill PJ, Balleine R : Moyamoya-like disease with inflammation. Eur Neurol 33 : 260-263, 1993   DOI
37 Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA : Cerebrovascular disease in childhood cancer survivors : a Children's Oncology Group Report. Neurology 73 : 1906-1913, 2009   DOI
38 Norton KK, Xu J, Gutmann DH : Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2 : 13-21, 1995   DOI
39 Ohba S, Nakagawa T, Murakami H : Concurrent Graves' disease and intracranial arterial stenosis/occlusion : special considerations regarding the state of thyroid function, etiology, and treatment. Neurosurg Rev 34 : 297-304; discussion 304, 2011   DOI
40 Parsa CF, Almer Z : Supranumerary optic disc vessels may indicate reduced systemic angiogenesis in Down syndrome. Br J Ophthalmol 92 : 432-433, 2008   DOI
41 Ram G, Chinen J : Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164 : 9-16, 2011   DOI
42 Rea D, Brandsema JF, Armstrong D, Parkin PC, deVeber G, MacGregor D, et al. : Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124 : e476-e483, 2009   DOI
43 Rosser TL, Vezina G, Packer RJ : Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64 : 553-555, 2005   DOI
44 Scott RM, Smith ER : Moyamoya disease and moyamoya syndrome. N Engl J Med 360 : 1226-1237, 2009   DOI
45 Shanahan P, Hutchinson M, Bohan A, O' Donoghue D, Sheahan K, Owens A : Hemichorea, moya-moya, and ulcerative colitis. Mov Disord 16 : 570-572, 2001   DOI
46 Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, et al. : Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68 : 932-938, 2007   DOI
47 Smith ER, Scott RM : Moyamoya : epidemiology, presentation, and diagnosis. Neurosurg Clin N Am 21 : 543-551, 2010   DOI
48 Suzuki S, Mitsuyama T, Horiba A, Fukushima S, Hashimoto N, Kawamata T : Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus : report of two cases. Clin Neurol Neurosurg 113 : 325-329, 2011   DOI
49 Tanigawara T, Yamada H, Sakai N, Andoh T, Deguchi K, Iwamura M : Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S225-S228, 1997
50 Vis JC, Duffels MG, Winter MM, Weijerman ME, Cobben JM, Huisman SA, et al. : Down syndrome : a cardiovascular perspective. J Intellect Disabil Res 53 : 419-425, 2009   DOI
51 Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL : Neurofibromatosis type 1 revisited. Pediatrics 123 : 124-133, 2009   DOI
52 Xu J, Ismat FA, Wang T, Yang J, Epstein JA : NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response. Circulation 116 : 2148-2156, 2007   DOI
53 Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. : Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31 : 930-935, 2000   DOI
54 Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG : Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 99 Suppl 2 : S58-S60, 1997